Adjuvant chemotherapy (AC) for stage III colorectal cancer (CRC) in the elderly: An Irish experience.

被引：0
|
作者：
Harrold, Emily
Greally, Megan
Peters, Niamh
Sui, Jane Sze Yin
McCaffrey, John
机构：
[1] Mater Misericordiae Univ Hosp, Dublin, Ireland
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Cork Univ Hosp, Cork, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
54
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world adoption of 3 months of adjuvant oxaliplatin chemotherapy in patients with stage III colorectal cancer (CRC).
    Krishnan, Tharani
    Vasconcelos, Joao Paulo Solar
    Lim, Howard J.
    Loree, Jonathan M.
    Davies, Janine Marie
    Gill, Karamjit
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 83 - 83
  • [22] Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non-elderly patients in stage III colorectal cancer
    Shiraishi, Takuya
    Ogawa, Hiroomi
    Shioi, Ikuma
    Ozawa, Naoya
    Osone, Katsuya
    Okada, Takuhisa
    Sohda, Makoto
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 91 - 101
  • [23] Is there alternative to FOLFOX adjuvant chemotherapy for stage III colorectal cancer patients?
    Esch, Anouk
    Coriat, Romain
    Perkins, Geraldine
    Brezault, Catherine
    Chaussade, Stanislas
    PRESSE MEDICALE, 2012, 41 (01): : 51 - 57
  • [24] The impact of adjuvant chemotherapy completion on prognosis of stage III colorectal cancer
    Nishimura, Junichi
    Takahashi, Yusuke
    Yasui, Masayoshi
    Asukai, Kei
    Yanagimoto, Yoshitomo
    Shinno, Naoki
    Sugimura, Keijiro
    Tomokuni, Akira
    Yamada, Daisaku
    Wada, Hiroshi
    Miyata, Hiroshi
    Ohue, Masayuki
    Yano, Masahiko
    CANCER SCIENCE, 2018, 109 : 1378 - 1378
  • [25] Adjuvant chemotherapy (AC) initiation and early discontinuation in elderly patients (EPs) with stage III colon cancer (CC)
    Ko, Jenny J.
    Kennecke, Hagen F.
    Lim, Howard John
    Gill, Sharlene
    Woods, Ryan
    Speers, Caroline
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] ADJUVANT CHEMOTHERAPY (AC) INITIATION AND EARLY DISCONTINUATION IN ELDERLY PATIENTS (EPS) WITH STAGE III COLON CANCER (CC)
    Cheung, W.
    Renouf, D.
    Lim, H.
    Kennecke, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 204 - 205
  • [27] Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Ensor, Joe
    Langer, Nathan
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Donald
    Meyer, Janelle Marie
    Sharif, Saima
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 9 - 9
  • [28] Is adjuvant chemotherapy necessary for T1 stage III colorectal cancer?
    Ishiguro, S.
    Yamamoto, S.
    Fujita, S.
    Akasu, T.
    Moriya, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 52 - 52
  • [29] Octogenarians with stage III colorectal cancer also benefit from adjuvant chemotherapy
    Duraes, Leonardo
    Stocchi, Luca
    Dietz, David
    Kalady, Matthew F.
    Kessler, Hermann P.
    Remzi, Feza H.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E83 - E83
  • [30] Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
    Ihara, Keisuke
    Yamaguchi, Satoru
    Shida, Yosuke
    Fujita, Junki
    Matsudera, Shotaro
    Kikuchi, Maiko
    Muroi, Hiroto
    Nakajima, Masanobu
    Sasaki, Kinro
    Tsuchioka, Takashi
    Kojima, Kazuyuki
    JOURNAL OF THE ANUS RECTUM AND COLON, 2019, 3 (02): : 78 - 83
12345